CD274 and neoplasm: In addition to tumor cells, genetically or thermally engineered mesenchymal stem cells up-regulate PD-L1 in their secreted EVs, prolonging allograft survival and offering therapeutic potential for autoimmune and chronic inflammatory diseases by promoting Treg differentiation [60-62].